Photobiomodulation is the mechanism by which non-ionizing optical radiation from lasers and non-coherent sources in the visible and near-infrared spectral range is absorbed by endogenous chromophores to elicit photo-physical and photo-chemical events at various biological scales, leading to physiological changes. Photobiomodulation is an emerging and rapidly expanding area of photonic research and therapeutic applications (PBMT) that have the potential to revolutionize modern health care. Currently, the risk to growth and acceptance of PBMT as predictable, safe and effective is the development and marketing of devices without a concurrent development of expertise and dissemination of fundamental knowledge in biomedical optics and photonics. The focus of the Photobiomodulation Technical Group will be to provide the necessary guidance and oversight to assure scientific accuracy in photobiomodulation basic research, clinical translation, and industrial development. The Photobiomodulation Technical Group also will establish an inclusive, timely and comprehensive list of effective and safe treatment parameters and mechanisms underpinning PBMT.
||U.S. Food and Drug Administration||Vice Chair
||American Institute of Medical Laser Appl||Events Officer
||Academy of Laser Dentistry||Events Officer
||THOR Photobiomodulation Ltd||Social Media Officer
||LiteCure, LLC||Social Media Officer
||University at Buffalo||Webinar Officer
||Massachusetts General Hospital||Webinar Officer
22 May 2017
21 August 2017
Keio Plaza Hotel, Tokyo
Become a members of our newest technical group today! OSA Members can join the Photobiomodulation Technical Group by updating their profile in My Account.
Join the Photobiomodulation Techical Group >>
In 2015, leaders of this technical group hosted an OSA Incubator Meeting
focused on the discussion and dissemination of scientifically sound research in the field of Photobiomodulation. You can read more about this meeting in the following blog posts: